The identification of herboxidiene as a specific modulator of USP19 splicing and its concomitant inhibitory effects on TGF-β/SMAD signaling and cancer migration further validates the opposing roles of USP19-ER and USP19-CY in these processed. The gene discussed is USP19; the disease is cancer.